|
Canada-ON-OAKVILLE Azienda Directories
|
Azienda News:
- Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse . . .
Vivodyne’s AI generates clinically predictive human datasets, already in use by most of the world’s top pharmaceutical firms Series A, led by Khosla Ventures, accelerates delivery of AI-led
- Vivodyne raises $40M for human tissue drug testing
Vivodyne, a San Francisco-based startup using lab-grown human tissues to discover and develop drugs, raised $40 million in a Series A led by Khosla Ventures Vivodyne Raises $40M For Human Tissue Drug Testing
- Vivodyne Secures $40M Series A to Scale AI-Powered Human Tissue Testing
– Vivodyne, a company pioneering an exclusively human-focused preclinical process, today announced it has raised $40M in new Series A funding led by Khosla Ventures, with participation from new
- Vivodyne raises $40M to replace animal testing with AI and robotics
The series A was led by Khosla Ventures, which also backed Vivodyne’s $38 million seed round in 2023 New investors in the round include Lingotto Investment Management, Helena Capital and Fortius Ventures, alongside returning backers Kairos Ventures, CS Ventures, Bison Ventures and MBX Capital
- Vivodyne seeks to sidestep animal models with $40 million raise
Philadelphia, USA-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered platform that tests drug candidates on lab-grown human tissues The latest round—led by Khosla Ventures with new backing from Lingotto Investment Management, Helena Capital and Fortius Ventures—will also support the launch of a new 23,000-square-foot facility in
|
|